Searched for
VOLINI
More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 26%Despite the US and Iran failing to reach an agreement over the weekend, the street is not entirely in a bearish mood. Market breadth is not...
- Companies back Smriti Mandhana, call out 'insensitive' social media scrutinyVice-captain of the Indian team that won the Women's Cricket World Cup in November this year, Mandhana has been the subject of extreme scru...
- Meet Delhi's extraordinary Uber driver Abdul Qadeer who offers more than just a rideAbdul Qadeer, an Uber driver in Delhi, has transformed his car into a mobile provision store, offering a wide range of complimentary items ...
- 300 drug formulations to have mandatory bar codes on packages soon to curb sales of spurious medicinesThe decision has been taken in order to curb the sales of spurious medicines. Furthermore, this will also help in checking the authenticity...
- YourPhysio raises $350K funding from Better Capital & Titan CapitalIn India alone, over 220 million people suffer from musculoskeletal conditions that affect joints, bones, muscles and ligaments - condition...
- Dilip Shanghvi’s daughter Vidhi to head consumer healthcare business at Sun PharmaThree years after son Aalok Shanghvi was inducted as emerging markets head of Sun Pharma, the company introduced daughter Vidhi Salgaocar a...
- Why working from home is not working outFlexible work remains popular at many organizations, but most companies want workers at work at least some-if not most-of the time.
- 'Return of the Singh' to generate revenue of Rs 12 CroreThis is an attempt of positioning boxing bout as sportainment in an era where IPL and league kabaddi and hockey have taken off, or are at l...
- ISL organisers, franchises upbeat ahead of season 2The second edition of Indian Super League has doubled its sponsorship revenue with the franchise owners expecting to break even by the end ...
- Sponsors set to pour in Rs 100 crore into ISL this year; existing firms like Hero, Maruti renew pactsThe Rupert Murdoch and Mukesh Ambani-promoted ISL is set to notch up Rs 100 crore in sponsorship revenues in its second season, up from abo...
- Sun Pharma to push Ranbaxy's OTC brands like Revital, Volini, ChericofAccording to top executives from both the companies, Ranbaxy's OTC portfolio is going to be one of the key segments for Sun Pharma with sig...
- Tata Docomo users can now carry forward their unused dataThe company said owing to the large volume of data consumed, it recognises the need to help customers manage data usage in an economical ma...
- Ranbaxy's Volini to be brand partner for Procam International eventsVolini will associate with Procam International promoted running events - Standard Chartered Mumbai Marathon, Airtel Delhi Half Marathon, a...
- Healthcare companies using Facebook to promote health products and their brandingWhen Parth Patel started his online pharmacy store in Ahmedabad, the venture threatened to be a non-starter.
- Ranbaxy signs Sonali Bendre, Trisha Krishnan to endorse VoliniThe company said it would kick off campaign featuring the female actors shortly across print, TV and other media.
- Ranbaxy launches 'Volini Duo' OTC painkiller across countryDrug firm Ranbaxy Laboratories today said its over-the-counter(OTC)division has launched a two-in-one painkiller, 'Volini Duo', across the ...
- Ranbaxy: Poor business outside India hurts numbersRanbaxy Labs, the country's largest pharma company, posted a dismal performance in its fourth quarter.
- Ranbaxy: Key markets of US, Europe not so promisingWhile the Street expected Ranbaxy to register a profit in the September quarter, the actual numbers — on a consolidated basis — exceeded ex...
Load More
